{"organizations": [], "uuid": "da4a8cfa89a0e17bedd879d1b342e2cb1d7364d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180523.html", "section_title": "Archive News &amp; Video for Wednesday, 23 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-eli-lillys-unit-bluegill-acquisiti/brief-eli-lillys-unit-bluegill-acquisition-offering-to-buy-all-of-armo-biosciencess-outstanding-shares-for-50-share-idUSFWN1SU0TE", "country": "US", "domain_rank": 408, "title": "BRIEF-Eli Lilly's Unit, Bluegill Acquisition Offering To Buy All Of Armo Biosciences's Outstanding Shares For $50/Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-23T21:22:00.000+03:00", "replies_count": 0, "uuid": "da4a8cfa89a0e17bedd879d1b342e2cb1d7364d3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-eli-lillys-unit-bluegill-acquisiti/brief-eli-lillys-unit-bluegill-acquisition-offering-to-buy-all-of-armo-biosciencess-outstanding-shares-for-50-share-idUSFWN1SU0TE", "ord_in_thread": 0, "title": "BRIEF-Eli Lilly's Unit, Bluegill Acquisition Offering To Buy All Of Armo Biosciences's Outstanding Shares For $50/Share", "locations": [], "entities": {"persons": [{"name": "eli lilly", "sentiment": "negative"}, {"name": "lilly", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-eli lilly", "sentiment": "negative"}, {"name": "armo biosciences inc", "sentiment": "negative"}, {"name": "armo biosciences", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 23 (Reuters) - ARMO Biosciences Inc:\n* ARMO BIOSCIENCES - ELI LILLY’S UNIT, BLUEGILL ACQUISITION CORP, OFFERING TO BUY ALL OF CO’S OUTSTANDING SHARES FOR $50/SHARE - SEC FILING\n* ARMO BIOSCIENCES - ON APRIL 13, LILLY HAD DELIVERED PRELIMINARY INDICATION OF INTEREST REGARDING ACQUISITION OF CO FOR $55/SHARE Source text: ( bit.ly/2s7FKjY ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://bit.ly/2s7FKjY", "https://www.youtube.com/user/ReutersVideo", "https://instagram.com/reuters/"], "published": "2018-05-23T21:22:00.000+03:00", "crawled": "2018-05-24T20:27:33.018+03:00", "highlightTitle": ""}